Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer

Surgical Oncology

Volumn 12, Issue 4, 2003, Pages 271-276

  Trocha, Steven D ^a   Giuliano, Armando E ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Locally advanced; Sentinel node

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; EXEMESTANE; FLUOROURACIL; ISOSULFAN BLUE; METHOTREXATE; RADIOISOTOPE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TAMOXIFEN; TECHNETIUM SULFUR COLLOID TC 99M;

ADVANCED CANCER; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; DIAGNOSTIC ACCURACY; DRUG CONTRAINDICATION; DRUG EFFICACY; HUMAN; MAMMOGRAPHY; MORBIDITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 1442286550     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2003.08.002     Document Type: Article

References (53)

1. Halsted W. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hospital Bulletin. 4:1894;297-323.
2. Auchincloss H. The nature of local recurrence following radical mastectomy. Cancer. 11:1958;611-618.
3. Patey D., Dyson W.H. The prognosis of carcinoma of the breast in relation to the type of operation performed. British Journal of Cancer. 2:1948;7-10.
4. Fisher B., Montague E., Redmond C.et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer. 39:1977;2827-2839.
5. Adair F., Berg J., Joubert L., Robbins G.F. Long-term follow-up of breast cancer patients. the 30-year report Cancer. 33:1974;1145-1150.
6. Pascual M.R., Rodriguez M., Zayas A., Moreno L.et al. Factors associated with prognosis in human breast cancer. II Multivariate stratification analysis Neoplasma. 30:1983;485-492.
7. Carter C.L., Allen C., Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 63:1989;181-187.
8. Cabanas R. An approach for the treatment of penile carcinoma. Cancer. 39:1977;456-466.
9. Morton D.L., Wen D.R., Wong J.H.et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Archives of Surgery. 127:1992;392-399.
10. Giuliano A., Kirgan D.M., Guenther J.M., Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Annals of Surgery. 220:1994;391-401.
11. Albertini J., Lyman G.H., Cox C.et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. Journal of the American Medical Association. 276:1996;1818-1822.
12. Offodile R., Hoh C., Barsky S.H.et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer. 82:1998;1704-1708.
13. Rubio I.T., Korourian S., Cowan C.et al. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Annals of Surgical Oncology. 5:1998;689-694.
14. Veronesi U., Paganelli G., Viale G.et al. Sentinel lymph node biopsy and axillary dissection in breast cancer. results in a large series Journal of National Cancer Institute. 91:1999;368-373.
15. Kuerer H.M., Hunt K.K., Newman L.A., Ross M.I.et al. Neoadjuvant chemotherapy in women with invasive breast carcinoma. conceptual basis and fundamental surgical issues Journal of the American College of Surgeons. 190:2000;350-363.
16. Powles T.J., Hickish T.F., Makris A.et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. Journal of Clinical Oncology. 13:1995;547-552.
17. Cunningham J.D., Weiss S.E., Ahmed S.et al. The efficacy of neoadjuvant chemotherapy compared to postoperative therapy in the treatment of locally advanced breast cancer. Cancer Investigation. 16:1998;80-86.
18. Fisher B., Bryant J., Wolmark N.et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Journal of Clinical Oncology. 16:1998;2672-2685.
19. Mauriac L., MacGrogan G., Avril A.et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3. cm a unicentre randomized trial with a 124-month median follow-up Institut Bergonie Bordeauz Groups Sein (IBBGS). Annals of Oncology. 10:1999;47-52.
20. Bonadonna G., Beronesi U., Brambilla C.et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. Journal of National Cancer Institute. 82:1990;1539-1545.
21. Touboul E., Lefranc J.P., Blondon J.et al. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3. cm or locally advanced non-inflammatory breast cancer Radiotherapy Oncology. 42:1997;219-229.
22. Merajver S.D., Weber B.L., Cody R.et al. Breast conservation and prolonged chemotherapy for locally advanced breast cancer. the University of Michigan experience Journal of Clinical Oncology. 15:1997;2873-2881.
23. Fisher B., Saffer E., Rudock C.et al. Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer Research. 49:1989;2002-2004.
24. O'Reilly M.S., Boehm T., Shing Y.et al. Endostatin. an endogenous inhibitor of angiogenesis and tumor growth Cell. 88:1997;277-285.
25. Kuerer H.M., Newman L.A., Fornage B.D., Dhingra K.et al. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Annals of Surgical Oncology. 5:1998;673-680.
26. Scholl S.M., Fourquet A., Asselain B., Pierga J.Y.et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomized trial. S6 European Journal of Cancer. 30A:1994;645-652.
27. DeLena M., Varini M., Zucali R., Rovini D.et al. Multimodal treatment for locally advanced breast cancer. Results of chemotherapy-radiotherapy versus chemotherapy-surgery. Cancer Clinical Trial. 4:1981;229-236.
28. Perloff M., Lesnick G.J., Korzun A., Chu F.et al. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma. a Cancer and Leukemia Group B study Journal of Clinical Oncology. 6:1988;261-269.
29. McCready D.R., Hortobagyi G.N., Kau S.W., Smith T.L.et al. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Archives of Surgery. 124:1989;21-25.
30. Bonadonna G., Valagussa P., Brambilla C., Ferrari L.et al. Primary chemotherapy in operable breast cancer. eight-year experience at the Milan Cancer Institute Journal of Clinical Oncology. 16:1998;93-100.
31. Botti C., Vici P., Lopez M., Scinto A.F.et al. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. Journal of American College Surgery. 181:1995;202-208.
32. Kuerer H.M., Newman L.A., Buzdar A.U., Hunt K.K.et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. American Journal of Surgery. 176:1998;502-509.
33. Fisher B., Wolmark N., Bauer M., Redmond C.et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surgery Gynecology and Obstetrics. 152:1981;763-772.
34. Bruneton J.N., Caramella E., Hery M., Aubanel D.et al. Axillary lymph node metastases in breast cancer. preoperative detection with US Radiology. 158:1986;325-326.
35. Pamilo M., Soiva M., Lavast E.M. Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. Journal of Ultrasound in Medicine. 8:1989;115-120.
36. Tate J.J., Lewis V., Archer T., Guyer P.G.et al. Ultrasound detection of axillary lymph node metastases in breast cancer. European Journal of Surgical Oncology. 15:1989;139-141.
37. de Freitas R. Jr., Costa M.V., Schneider S.V., Nicolau M.A., Marussi E. Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. European Journal of Surgical Oncology. 17:1991;240-244.
38. Bonnema J., van Geel A.N., van Ooijen B., Mali S.P.et al. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients. new diagnostic method World Journal of Surgery. 21:1997;270-274.
39. Herrada J., Iyer R.B., Atkinson E.N., Sneige N.et al. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clinical Cancer Research. 3:1997;1569-1569.
40. Giuliano A., Jones R.C., Brennan M., Statman R. Sentinel lymphadenectomy in breast cancer. Journal of Clinical Oncology. 15:1997;2345-2350.
41. Barnwell J.M., Arredondo M.A., Kollmorgen D.et al. Sentinel node biopsy in breast cancer. Annals of Surgical Oncology. 5:1998;126-130.
42. Feldman S.M., Krag D.N., McNally R.K.et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. Journal of American College Surgery. 188:1999;248-254.
43. Van der Ent F., Kengen R.A., van der Pol H.A., Hoofwijk A.G. Sentinel node biopsy in 70 unselected patients with breast cancer. increased feasibility by using 10 mci radiocolloid in combination with a blue dye tracer European Journal of Surgical Oncology. 25:1999;24-29.
44. Cody H.S. III Sentinel lymph node mapping in breast cancer. Oncology. 13:1999;25-43.
45. Bedrosian I., Reynolds C., Mick R., Callans L.S.et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer. 88:2000;2540-2545.
46. Chung M.H., Wei Y., Giuliano A.E. Role of sentinel node dissection in the management of large (≥5. cm) invasive breast cancer Annals of Surgical Oncology. 8:2001;688-692.
47. Nason K.S., Anderson B.O., Byrd D.R., Dunnwald L.K.et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer. 89:2000;2187-2194.
48. Breslin T.M., Cohen L., Sahin A., Fleming J.B.et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. Journal of Clinical Oncology. 18:2000;3480-3486.
49. Haid A., Tausch C., Land A., Lutz J.et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer. 92:2001;1080-1084.
50. Tafra L., Verbanac K.M., Lannin D.R. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. American Journal of Surgery. 182:2001;312-315.
51. Stearns V., Ewing C.D., Slack R., Penannen M.F.et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Annals of Surgical Oncology. 9:2002;235-242.
52. Fisher B., Bryant J., Wolmark N.et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Journal of Clinical Oncology. 16:1998;2672-2685.
53. Julian T.B., Patel N., Dusi D., Olson P.et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. American Journal of Surgery. 182:2001;407-410.